Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models

BACKGROUND: Type 2 diabetes may occur as a result of HIV infection and/or its treatment. Gliclazide is a widely used drug for the treatment of type 2 diabetes. Efavirenz and nevirapine are widely used non-nucleoside reverse transcriptase inhibitors for the treatment of HIV infection. The role of Efa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastan, SK, Kumar, K Eswar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765430/
https://www.ncbi.nlm.nih.gov/pubmed/19825151
http://dx.doi.org/10.1186/1758-5996-1-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765430/
https://www.ncbi.nlm.nih.gov/pubmed/19825151
http://dx.doi.org/10.1186/1758-5996-1-15

Ejemplares similares